Edwards Lifesciences (EW) Shares Issued (2009 - 2026)

Edwards Lifesciences' Shares Issued history runs 18 years deep, the most recent figure standing at $68.9 million for Q1 2026.

• In Q1 2026, Shares Issued rose 38.08% year-over-year to $68.9 million; the TTM figure through Mar 2026 stood at $193.1 million (up 15.42% YoY), while the FY2025 annual figure was $174.1 million, down 3.01% from the prior year.
• Shares Issued was $68.9 million for Q1 2026 at Edwards Lifesciences, up from $32.3 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $68.9 million in Q1 2026 to a low of $27.5 million in Q4 2022.
• Historically, Shares Issued has averaged $43.5 million across 5 years, with a median of $37.5 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Shares Issued surged 48.21% in 2024, then fell 19.65% in 2025.
• A 5-year view of Shares Issued shows it stood at $27.5 million in 2022, then climbed by 20.73% to $33.2 million in 2023, then slipped by 13.86% to $28.6 million in 2024, then advanced by 12.94% to $32.3 million in 2025, then soared by 113.31% to $68.9 million in 2026.
• The last three Shares Issued figures came in at $68.9 million (Q1 2026), $32.3 million (Q4 2025), and $34.7 million (Q3 2025), per Business Quant data.